Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term PAH disease management with normative values from the national health and nutrition examination survey

Mayo Clinic Proceedings

Volumn 86, Issue 2, 2011, Pages 105-112

  Burger, Charles D ^a   Foreman, Aimee J ^b   Miller, Dave P ^b   Safford, Robert E ^a   McGoon, Michael D ^c   Badesch, David B ^d  

^a MAYO CLINIC   (United States)

^b ICON CLINICAL RESEARCH   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANOREXIGENIC AGENT; COCAINE; METHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PULMONARY HYPERTENSION; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; UNDERWEIGHT;

EID: 79551664063     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0394     Document Type: Article

References (24)

1. Catenacci VA, Hill JO, Wyatt HR. The obesity epidemic. Clin Chest Med. 2009;30:415-444, vii.
2. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132:2087-2102.
3. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137:376-387.
4. Taichman DB, Mandel J. Epidemiology of pulmonary arterial hypertension. Clin Chest Med. 2007;28:1-22, vii.
5. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104:2797-2802.
6. Williams W III, Safford R, Heckman M, Crook J, Burger C. Pulmonary arterial hypertension and obesity. Open Obesity J. 2010;2:132-136.
7. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. Circulation. 2009;119:2250-2294.
8. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43-S54.
9. McGoon MD, Krichman A, Farber HW, et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008;83:923-931.
10. Frost AE, Badesch DB, Barst RJ, et al. The changing picture of pulmonary arterial hypertension (PAH) patients in the United States: how the REVEAL registry differs from historic and non-US contemporary registries [published online ahead of print June 17, 2010]. Chest. doi 10.1378/chest.10-0075.
11. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). NCHS Research Data Center (RDC). http://www. cdc.gov/rdc/. Accessed October 25, 2010.
12. Taraseviciute A, Voelkel NF. Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res. 2006;11:198-202. (Pubitemid 43750524)
13. Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009;179:509-516.
14. Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban JP. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55:934-939.
15. Kessler R, Chaouat A, Weitzenblum E, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J. 1996;9:787-794.
16. Abenhaim L, Moride Y, Brenot F, et al; International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609-616.
17. Michelakis ED, Weir EK. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Am J Med Sci. 2001;321:292-299.
18. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest. 2000;117:870-874.
19. Bolland MJ, Grey AB, Gamble GD, Reid IR. CLINICAL Review: low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2007;92:4522-4528.
20. Ockenga J, Grimble R, Jonkers-Schuitema C, et al. ESPEN guidelines on enteral nutrition: wasting in HIV and other chronic infectious diseases. Clin Nutr. 2006;25:319-329.
21. Dua JS, Cooper AR, Fox KR, Graham Stuart A. Physical activity levels in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2007;14:287-293.
22. Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13:612-616.
23. Pinto NM, Marino BS, Wernovsky G, et al. Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics. 2007;120:e1157-e1164.
24. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation (WHO Technical Report Series 894). Vol 894. Geneva: World Health Organization. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.